Learn / RXRX
NASDAQ: RXRX
Recursion Pharmaceuticals (RXRX) stock, explained like you're 5
Recursion Pharmaceuticals trades on the Nasdaq under the ticker RXRX. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
- Ticker
- RXRX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 2.3 billion dollars
Is Recursion Pharmaceuticals a small, medium or large cap company?
No. Recursion Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Recursion Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves RXRX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- RXRX Stock Soars Pre Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ (Stocktwits)
- Recursion Pharmaceuticals (RXRX) Stock Sees Modest Fair Value Lift After Analyst Target Revisions (Yahoo Finance)
- Why Recursion Pharmaceuticals Stock Is In Focus After Drug Data And Sanofi Milestone (Yahoo Finance)
- Recursion Pharmaceuticals Shares Rise After Hours Goldman Sachs Group (NYSE:GS), Morgan Stanley (NYSE:M (Benzinga)
- Two patients had at least 98% fewer polyps in the upper digestive tract (Stock Titan)
Follow RXRX in your daily brief
Each trading day at 5 PM ET we post what happened to Recursion Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow RXRX
Questions about Recursion Pharmaceuticals stock
What does Recursion Pharmaceuticals do?
Recursion Pharmaceuticals trades on the Nasdaq under the ticker RXRX. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
What is the ticker symbol for Recursion Pharmaceuticals?
Recursion Pharmaceuticals trades under the ticker RXRX on the Nasdaq.
What is Recursion Pharmaceuticals's market cap?
Recursion Pharmaceuticals is a mid cap stock with a market cap of about 2.3 billion dollars.
How does Recursion Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves RXRX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow RXRX stock every day?
Add RXRX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.